Skip to main content

1-5 of 5 results for subject:"Medical treatments"

Member X
Baroness Morgan of Drefelin
Subject X
Medical equipment

Type

House

Session

Year

Department

Member

More
Morgan of Drefelin, Baroness (5)

Primary member

Answering member

Legislative stage

Legislation

Subject

More
Medical equipment (5)

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

My Lords, I declare an interest as chief executive of the research and care charity Breast Cancer Now and as chair of the National Cancer Research Institute.

I would like to start by congratulating the noble Baroness, Lady Cumberlege, and her colleagues on her committee, for her report and her compelling...

Member
Baroness Morgan of Drefelin (Crossbench)
Type
Proceeding contributions
Date
2 September 2020
Reference
805 cc420-2
House
House of Lords

My Lords, this is a very important debate. I support the idea of keeping the qualifying period for PIP at three months. I also hope this debate will look at the idea of the prospective period moving from six to nine months if the Minister sees that as an appropriate...

Member
Baroness Morgan of Drefelin (Crossbench)
Type
Proceeding contributions
Date
16 November 2011
Reference
732 c292-4GC
House
House of Lords

If the Minister is going to write, would he also look at explaining how many of those are dependent on local authority provision? Much of the kind of help that he is talking about is sometimes dependent on having DLA.

Member
Baroness Morgan of Drefelin (Crossbench)
Type
Proceeding contributions
Date
16 November 2011
Reference
732 c299GC
House
House of Lords

I am sorry to interrupt the Minister again. Does he agree that one of the thrusts of modern health care—particularly in cancer care, where I have an interest—is to try to keep people at home for as long as possible and not requiring hospitalisation? One of the brilliant aspects of...

Member
Baroness Morgan of Drefelin (Crossbench)
Type
Proceeding contributions
Date
16 November 2011
Reference
732 c300GC
House
House of Lords

In that case, perhaps I may ask another question. If this is not what it is for, we need to understand what the implications are. People who have DLA now and are being treated for cancer—to give an example of a sudden-onset condition—are utilising the benefit in that way. As...

Member
Baroness Morgan of Drefelin (Crossbench)
Type
Proceeding contributions
Date
16 November 2011
Reference
732 c300GC
House
House of Lords